Date Title Description PDF
23 Feb 2022 On business and financial situation The Company releases the press release related to the full year 2021 financial results Download
23 Feb 2022 On business and financial situation The Company releases the full year 2021 financial results presentation Download
23 Feb 2022 About corporate governance The Company informs about the agreements adopted by the Board of Directors  Download
22 Feb 2022 On buy-back programmes ROVI reports the end of the share buy-back programme, effective as of 3 November 2021, and the launching of a new share buy-back programme, effective as of 23 February 2022.     Download
16 Feb 2022 On business and financial situation Moderna and ROVI announced that they expand their long-term collaboration for the manufacture of mRNA medicines over the next ten years       Download

Pages

Date Title Description PDF
31 May 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 24 May and 30 May 2024 Download
24 May 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 17 May and 23 May 2024 Download
21 May 2024 Announcement of general shareholders’ meeting Publication of the announcement of the call to the General Shareholders’ Meeting and the documentation related thereto.   Download
17 May 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 10 May and 16 May 2024 Download
10 May 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 2 May and 9 May 2024 Download

Pages

Date Title Description PDF
08 Oct 2018 Share capital increases and reductions Information on the registration in the Commercial Registry of Madrid of the notarial deed regarding the capital increase Download
05 Oct 2018 Buy-back programmes, stabilisation and treasury stock Information about the possibility that Jefferies International Limited carries out stabilisation transactions within the framework of the capital increase excluding pre-emptive subscription rights of the existing shareholders of Laboratorios Farmacéuticos Rovi, S.A. Download
04 Oct 2018 Share capital increases and reductions Directors’ Report and Independent Expert Report related to capital increase excluding preferential subscription rights Download
04 Oct 2018 Liquidity contracts and specialists The Company informs that has temporarily suspended liquidity agreement with JB Capital Markets, Sociedad de Valores, S.A.U. Download
04 Oct 2018 Share capital increases and reductions Information on price fixing and outcome of the private placement related to capital increase addressed to institutional investors, excluding preferential subscription rights Download

Pages